Warnock; Mark

Patent Applications and Registrations

Patent applications and USPTO patent grants for Warnock; Mark.The latest application filed is for "plasminogen activator inhibitor-1 inhibitors and methods of use thereof".

Company Profile

0.7.6

Warnock; Mark - Brighton MI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Plasminogen Activator Inhibitor-1 Inhibitors And Methods Of Use Thereof App 20170291893 - Lawrence; Daniel A. ; et al.	2017-10-12
Plasminogen activator inhibitor-1 inhibitors and methods of use thereof Grant 9,718,760 - Lawrence , et al. August 1, 2	2017-08-01
Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism Grant 9,527,878 - Lawrence , et al. December 27, 2	2016-12-27
Plasminogen Activator Inhibitor-1 Inhibitors And Methods Of Use Thereof To Modulate Lipid Metabolism App 20160009748 - Lawrence; Daniel A. ; et al.	2016-01-14
Plasminogen Activator Inhibitor-1 Inhibitors And Methods Of Use Thereof App 20150315178 - Lawrence; Daniel A. ; et al.	2015-11-05
Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism Grant 9,120,744 - Lawrence , et al. September 1, 2	2015-09-01
Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism Grant 9,096,501 - Lawrence , et al. August 4, 2	2015-08-04
Plasminogen Activator Inhibitor-1 Inhibitors and Methods of Use Thereof to Modulate Lipid Metabolism App 20140343321 - Lawrence; Daniel A. ; et al.	2014-11-20
Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism Grant 8,759,327 - Lawrence , et al. June 24, 2	2014-06-24
Plasminogen Activator Inhibitor-1 Inhibitors and Methods of Use Thereof to Modulate Lipid Metabolism App 20100137194 - Lawrence; Daniel A. ; et al.	2010-06-03
Plasminogen Activator Inhibitor-1 Inhibitors And Methods Of Use Thereof To Modulate Lipid Metabolism App 20090011055 - Lawrence; Daniel A. ; et al.	2009-01-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.